Research publications from Maverex
We share peer-reviewed research publications across oncology, cardiovascular, infectious disease and much more.
Browse or search our latest publications.
Transparency in decision modelling: what, why, who and how?
Sampson CJ, Arnold R, Bryan S, Clarke P, Ekins S, Hatswell A, Hawkins N, Langham S, Marshall D, Sadatsafavi M, Sullivan W, Wilson ECF, Wrightson T. Transparency in decision modelling: what, why, who and how? Pharmacoeconomics 2019;37(11):1355–69
Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
Langham S, Lewis J, Pooley N, Embleton N, Langham J, Han MK, Chalmers JD. Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic and descriptive review. Respir Res 2019;20(1):242
Budget impact analysis of methoxyflurane (Penthrox®) for emergency relief of moderate-to-severe trauma pain in the Swedish setting
Kenworthy J, Langham S, Wright A, Dunlop W. Budget impact analysis of methoxyflurane (Penthrox®) for emergency relief of moderate-to-severe trauma pain in the Swedish setting. Value Health 2018;21(Suppl 3):S443
Choosing the right software for HTA economic models: a comparison of four programmes recommended by the National Institute for Health and Care Excellence
Wright A, Embleton N, Langham S. Choosing the right software for HTA economic models: a comparison of four programmes recommended by the National Institute for Health and Care Excellence. Value Health 2018;21(Suppl 3):S380
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom
Langham S, Wright A, Kenworthy J, Grieve R, Dunlop WCN. Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the UK. Value Health 2018;21(4):407–15. Open access ‘R’ and ‘Excel model’
Health technology assessment of companion diagnostics alongside therapeutic agents in oncology: experience of the NICE technology appraisal programme
Langham S, Lewis J. Health technology assessment of companion diagnostics alongside therapeutic agents in oncology: experience of the NICE technology appraisal programme. Value Health 2018;21(Suppl 3):S272
Conducting and reporting indirect treatment comparisons: a critical appraisal of oncology technology appraisals
Langham J, Langham S. Conducting and reporting indirect treatment comparisons: a critical appraisal of oncology technology appraisals. Value Health 2018;21(Suppl 3):S68
Modelled effects of a pediatric triple-chamber-bag (3CB) system on payer costs and clinical outcomes in pre-term neonates across France, Germany, and Italy
Kriz A, Migliore A, Wright A, Piaggio T. Modelled effects of a pediatric triple-chamber-bag (3CB) system on payer costs and clinical outcomes in pre-term neonates across France, Germany, and Italy. Value Health 2018;21(Suppl 3): S216–7
Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the UK
Langham S, Wright A, Kenworthy J, Grieve R, Dunlop WCN. Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the UK. Value Health 2018;21(4):407–15.
